These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4006735)

  • 1. Anaphylactoid reactions associated with parenteral cyclosporine use: possible role of Cremophor EL.
    Howrie DL; Ptachcinski RJ; Griffith BP; Hardesty RJ; Rosenthal JT; Burckart GJ; Venkataramanan R
    Drug Intell Clin Pharm; 1985 Jun; 19(6):425-7. PubMed ID: 4006735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL.
    Theis JG; Liau-Chu M; Chan HS; Doyle J; Greenberg ML; Koren G
    J Clin Oncol; 1995 Oct; 13(10):2508-16. PubMed ID: 7595701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of anaphylactoid reactions: improper preparation of high-dose intravenous cyclosporine leads to bolus infusion of Cremophor EL and cyclosporine.
    Liau-Chu M; Theis JG; Koren G
    Ann Pharmacother; 1997 Nov; 31(11):1287-91. PubMed ID: 9391679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Well-tolerated oral cyclosporine in a case of hypersensitivity to parenteral cyclosporine in postallogeneic bone marrow transplantation.
    Moeinian M; Sotoude H; Mohebbi Z; Asadollahi-Amin A; Mozafari R
    Indian J Pharmacol; 2018; 50(2):94-96. PubMed ID: 30100659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor ® EL.
    Ehinger KH; Hansson MJ; Sjövall F; Elmér E
    Clin Drug Investig; 2013 Jan; 33(1):25-34. PubMed ID: 23179472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine-induced anaphylaxis.
    Kuiper RA; Malingré MM; Beijnen JH; Schellens JH
    Ann Pharmacother; 2000; 34(7-8):858-61. PubMed ID: 10928395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cremophor EL Alters the Plasma Protein Binding and Pharmacokinetic Profile of Valspodar in Rats.
    Binkhathlan Z
    Drug Res (Stuttg); 2017 Oct; 67(10):591-595. PubMed ID: 28628923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylactic reaction and cardiopulmonary arrest following intravenous cyclosporine.
    Friedman LS; Dienstag JL; Nelson PW; Russell PS; Cosimi AB
    Am J Med; 1985 Feb; 78(2):343-5. PubMed ID: 3970058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE-mediated anaphylaxis after first intravenous infusion of cyclosporine.
    Ebo DG; Piel GC; Conraads V; Stevens WJ
    Ann Allergy Asthma Immunol; 2001 Sep; 87(3):243-5. PubMed ID: 11570623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review.
    Volcheck GW; Van Dellen RG
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):159-63. PubMed ID: 9494448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells activation and high blood tryptase levels due to paclitaxel administration. Is Cremophor EL the culprit?: A case report.
    D'Errico S; Baldari B; Arcangeli M; Santurro A; Frati P; Fineschi V
    Medicine (Baltimore); 2020 Oct; 99(43):e22814. PubMed ID: 33120804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anaphylactoid reactions to an injectable solution of a cremophor-containing solution of multivitamins].
    Mounier P; Laroche D; Divanon F; Mosquet B; Vergnaud MC; Esse-Comlan A; Piquet MA; Bricard H
    Therapie; 1995; 50(6):571-3. PubMed ID: 8745958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study.
    Szebeni J; Muggia FM; Alving CR
    J Natl Cancer Inst; 1998 Feb; 90(4):300-6. PubMed ID: 9486816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hemodynamic effects of Cremophor-EL.
    Bowers VD; Locker S; Ames S; Jennings W; Corry RJ
    Transplantation; 1991 Apr; 51(4):847-50. PubMed ID: 2014541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for preventing reactions secondary to Cremophor EL.
    Michaud LB
    Ann Pharmacother; 1997 Nov; 31(11):1402-4. PubMed ID: 9391700
    [No Abstract]   [Full Text] [Related]  

  • 16. Anaphylactic reaction to first exposure to cyclosporine.
    Magalini SC; Nanni G; Agnes S; Citterio F; Castagneto M
    Transplantation; 1986 Oct; 42(4):443-4. PubMed ID: 3765054
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholestasis in the rat by means of intravenous administration of cyclosporine vehicle, Cremophor EL.
    Roman ID; Monte MJ; Esteller A; Jimenez R
    Transplantation; 1989 Oct; 48(4):554-8. PubMed ID: 2799907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful switch to oral tacrolimus in a patient with hypersensitivity reaction to parenteral vitamin K, cyclosporine, and tacrolimus: A case report.
    Taghvaye-Masoumi H; Sadeghi K; Hadjibabaie M
    J Oncol Pharm Pract; 2020 Jun; 26(4):986-988. PubMed ID: 31446869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylactoid reactions with intraperitoneal cisplatin.
    Hebert ME; Blivin JL; Kessler J; Soper JT; Oleson JR
    Ann Pharmacother; 1995 Mar; 29(3):260-3. PubMed ID: 7606071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylaxis caused by anti-cremophor EL IgG STS antibodies in a case of reaction to althesin.
    Moneret-Vautrin DA; Laxenaire MC; Viry-Babel F
    Br J Anaesth; 1983 May; 55(5):469-71. PubMed ID: 6849729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.